Scholarlink

<p>Due to insufficient sensitivity of mammography in dense breasts, ultrasonography and MRI have been incorporated into breast screening, despite increasing false positive risks. While optical imaging has been suggested to improve specificity, its effectiveness in diagnosing breast lesions remains unclear. This study investigates the impact of clinical factors on the diagnostic performance of diffuse optical spectroscopic imaging (DOSI) for detecting breast malignancies. Between March and May 2022, 62 women with 62 breast lesions (37 malignant, 25 benign) were analyzed using DOSI to quantify the concentrations of tissue chromophores (HbO<sub>2</sub>, HHb, water, lipid), total hemoglobin concentration (THC), oxygen saturation (StO<sub>2</sub>) and tissue optical index (TOI). The ratio of each parameter was compared to those of contralateral normal breasts, and diagnostic performance was assessed using area under the curve (AUC) values. The TOI ratio demonstrated the highest AUC (0.904, 95% CI 0.831–0.977), followed by water (0.836, 95% CI 0.736–0.936) and THC (0.738, 95% CI 0.613–0.864). The TOI ratio showed no significant differences in diagnostic performance based on clinical factors, whereas the water and THC ratios varied according to breast thickness, nipple distance, and BMI. Overall, the TOI ratio demonstrated strong diagnostic performance, suggesting its potential for universal application in breast cancer diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of clinical factors on the diagnostic performance of diffuse optical spectroscopic imaging for breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月25日

查看全文
  • Yeji Kwon,
  • Jiyoung Yoon,
  • Chanhui Lim,
  • Heesun Hong,
  • Sung-Ho Han,
  • Min Jung Kim

摘要

Due to insufficient sensitivity of mammography in dense breasts, ultrasonography and MRI have been incorporated into breast screening, despite increasing false positive risks. While optical imaging has been suggested to improve specificity, its effectiveness in diagnosing breast lesions remains unclear. This study investigates the impact of clinical factors on the diagnostic performance of diffuse optical spectroscopic imaging (DOSI) for detecting breast malignancies. Between March and May 2022, 62 women with 62 breast lesions (37 malignant, 25 benign) were analyzed using DOSI to quantify the concentrations of tissue chromophores (HbO2, HHb, water, lipid), total hemoglobin concentration (THC), oxygen saturation (StO2) and tissue optical index (TOI). The ratio of each parameter was compared to those of contralateral normal breasts, and diagnostic performance was assessed using area under the curve (AUC) values. The TOI ratio demonstrated the highest AUC (0.904, 95% CI 0.831–0.977), followed by water (0.836, 95% CI 0.736–0.936) and THC (0.738, 95% CI 0.613–0.864). The TOI ratio showed no significant differences in diagnostic performance based on clinical factors, whereas the water and THC ratios varied according to breast thickness, nipple distance, and BMI. Overall, the TOI ratio demonstrated strong diagnostic performance, suggesting its potential for universal application in breast cancer diagnosis.